20-53253630-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_173485.6(TSHZ2):c.172C>T(p.Pro58Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,613,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173485.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSHZ2 | NM_173485.6 | c.172C>T | p.Pro58Ser | missense_variant | 2/3 | ENST00000371497.10 | NP_775756.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSHZ2 | ENST00000371497.10 | c.172C>T | p.Pro58Ser | missense_variant | 2/3 | 1 | NM_173485.6 | ENSP00000360552 | P1 | |
TSHZ2 | ENST00000603338.2 | c.163C>T | p.Pro55Ser | missense_variant | 2/3 | 2 | ENSP00000475114 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151960Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251474Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135906
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.0000399 AC XY: 29AN XY: 727246
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151960Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74190
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.172C>T (p.P58S) alteration is located in exon 2 (coding exon 2) of the TSHZ2 gene. This alteration results from a C to T substitution at nucleotide position 172, causing the proline (P) at amino acid position 58 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at